Pre-Conference Workshop on Recombinant Factors

Programme

Pre-conference Workshop on Recombinant Factors, 18 April 2016

Immunology of F.VIII
Overview on Factor VIII deficiencies
How factor VIII is seen by the immune system
Epitope recognition by antibodies
Epitope, neotope, cryptotope
Dr Stephan Kiessig

From bench to bedside - monitoring evolving FVIII inhibitors
Neutralizing antibodies against FVIII as the major complication in the replacement therapy of haemophilia A patients with FVIII products
Current understanding of the root cause for the development of FVIII inhibitors
Novel approaches to monitor evolving FVIII inhibitors in patients
Dr Birgit Reipert

Regulatory experiences with recombinant coagulation factors – Quality issues
Different types of coagulation factors – full-length, domain-deleted, fused
Testing issues
Adventitious agents
Dr Manuela Leitner

Assessing, managing and evolving safety and efficacy of coagulation factors
Aspects of Regulatory Science
Aspects of Clinical Medicine
Aspects of Health Services Research
Dr Dorothea Stahl

Panel Discussion